Dexamethasone upregulates FOXP3 expression without increasing regulatory activity

Immunobiology

Volumn 216, Issue 3, 2011, Pages 386-392

  Prado, Catuxa ^a   Gómez, Jesús ^b   López, Patricia ^a   de Paz, Banesa ^a   Gutiérrez, Carmen ^a,b   Suárez, Ana ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Anergy; Corticoids; FOXP3; Regulatory T cells; Systemic lupus erythematosus

Indexed keywords

DEXAMETHASONE; MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL ACTIVITY; CONTROLLED STUDY; DRUG MECHANISM; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADULT; ANTIGENS, CD4; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DEXAMETHASONE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREDNISONE; RNA, MESSENGER; T-LYMPHOCYTES, REGULATORY; UP-REGULATION;

EID: 79251595110     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2010.06.013     Document Type: Article

References (36)

1. Abraham M., Karni A., Dembinsky A., Miller A., Gandhi R., Anderson D., Weiner H.L. In vitro induction of regulatory T cells by anti-CD3 antibody in humans. J. Autoimmun. 2008, 30:21-28.
2. Allan S.E., Crome S.Q., Crellin N.K., Passerini L., Steiner T.S., Bacchetta R., Roncarolo M.G., Levings M.K. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int. Immunol. 2007, 19:345-354.
3. Allan S.E., Passerini L., Bacchetta R., Crellin N., Dai M., Orban P.C., Ziegler S.F., Roncarolo M.G., Levings M.K. The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. J. Clin. Invest. 2005, 115:3276-3284.
4. Azab N.A., Bassyouni I.H., Emad Y., bd El-Wahab G.A., Hamdy G., Mashahit M.A. CD4+CD25+ regulatory T cells (TREG) in systemic lupus erythematosus (SLE) patients: the possible influence of treatment with corticosteroids. Clin. Immunol. 2008, 127:151-157.
5. Bacchetta R., Gambineri E., Roncarolo M.G. Role of regulatory T cells and FOXP3 in human diseases. J. Allergy Clin. Immunol. 2007, 120:227-235.
6. Buckner J.H., Ziegler S.F. Regulating the immune system: the induction of regulatory T cells in the periphery. Arthritis Res. Ther. 2004, 6:215-222.
7. Chen W., Jin W., Hardegen N., Lei K.J., Li L., Marinos N., McGrady G., Wahl S.M. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor FOXP3. J. Exp. Med. 2003, 198:1875-1886.
8. Chen X., Murakami T., Oppenheim J.J., Howard O.M. Differential response of murine CD4+CD25+ and CD4+CD25- T cells to dexamethasone-induced cell death. Eur. J. Immunol. 2004, 34:859-869.
9. Chen X., Oppenheim J.J., Winkler-Pickett R.T., Ortaldo J.R., Howard O.M. Glucocorticoid amplifies IL-2-dependent expansion of functional FOXP3(+)CD4(+)CD25(+) T regulatory cells in vivo and enhances their capacity to suppress EAE. Eur. J. Immunol. 2006, 36:2139-2149.
10. Chung I.Y., Dong H.F., Zhang X., Hassanein N.M., Howard O.M., Oppenheim J.J., Chen X. Effects of IL-7 and dexamethasone: induction of CD25, the high affinity IL-2 receptor, on human CD4+ cells. Cell Immunol. 2004, 232:57-63.
11. Fontenot J.D., Gavin M.A., Rudensky A.Y. FOXP3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 2003, 4:330-336.
12. Franchimont D., Galon J., Vacchio M.S., Fan S., Visconti R., Frucht D.M., Geenen V., Chrousos G.P., Ashwell J.D., O'Shea J.J. Positive effects of glucocorticoids on T cell function by up-regulation of IL-7 receptor alpha. J. Immunol. 2002, 168:2212-2218.
13. Gavin M.A., Torgerson T.R., Houston E., DeRoos P., Ho W.Y., Stray-Pedersen A., Ocheltree E.L., Greenberg P.D., Ochs H.D., Rudensky A.Y. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:6659-6664.
14. Gomez J., Suarez A., Lopez P., Mozo L., Diaz J.B., Gutierrez C. Systemic lupus erythematosus in Asturias, Spain: clinical and serologic features. Medicine (Baltimore) 2006, 85:157-168.
15. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor FOXP3. Science 2003, 299:1057-1061.
16. Karagiannidis C., Akdis M., Holopainen P., Woolley N.J., Hense G., Ruckert B., Mantel P.Y., Menz G., Akdis C.A., Blaser K., Schmidt-Weber C.B. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J. Allergy Clin. Immunol. 2004, 114:1425-1433.
17. Ling Y., Cao X., Yu Z., Ruan C. Circulating dendritic cells subsets and CD4+FOXP3+ regulatory T cells in adult patients with chronic ITP before and after treatment with high-dose dexamethasome. Eur. J. Haematol. 2007, 79:310-316.
18. Lopez P., Gomez J., Prado C., Gutierrez C., Suarez A. Influence of functional interleukin 10/tumor necrosis factor-alpha polymorphisms on interferon-alpha, IL-10, and regulatory T cell population in patients with systemic lupus erythematosus receiving antimalarial treatment. J. Rheumatol. 2008, 35:1559-1566.
19. Lopez P., Mozo L., Gutierrez C., Suarez A. Epidemiology of systemic lupus erythematosus in a northern Spanish population: gender and age influence on immunological features. Lupus 2003, 12:860-865.
20. Mahic M., Yaqub S., Bryn T., Henjum K., Eide D.M., Torgersen K.M., Aandahl E.M., Tasken K. Differentiation of naive CD4+ T cells into CD4+CD25+FOXP3+ regulatory T cells by continuous antigen stimulation. J. Leukoc. Biol. 2008, 83:1111-1117.
21. Mantel P.Y., Ouaked N., Ruckert B., Karagiannidis C., Welz R., Blaser K., Schmidt-Weber C.B. Molecular mechanisms underlying FOXP3 induction in human T cells. J. Immunol. 2006, 176:3593-3602.
22. Morgan M.E., van Bilsen J.H., Bakker A.M., Heemskerk B., Schilham M.W., Hartgers F.C., Elferink B.G., van der Z.L., de Vries R.R., Huizinga T.W., Ottenhoff T.H., Toes R.E. Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. Hum. Immunol. 2005, 66:13-20.
23. Pillai V., Karandikar N.J. Attack on the clones? Human FOXP3 detection by PCH101, 236A/E7, 206D, and 259D reveals 259D as the outlier with lower sensitivity. Blood 2008, 111:463-464.
24. Pillai V., Ortega S.B., Wang C.K., Karandikar N.J. Transient regulatory T-cells: a state attained by all activated human T-cells. Clin. Immunol. 2007, 123:18-29.
25. Rao P.E., Petrone A.L., Ponath P.D. Differentiation and expansion of T cells with regulatory function from human peripheral lymphocytes by stimulation in the presence of TGF-{beta}. J. Immunol. 2005, 174:1446-1455.
26. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 1995, 155:1151-1164.
27. Schubert L.A., Jeffery E., Zhang Y., Ramsdell F., Ziegler S.F. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J. Biol. Chem. 2001, 276:37672-37679.
28. Somerset D.A., Zheng Y., Kilby M.D., Sansom D.M., Drayson M.T. Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology 2004, 112:38-43.
29. Suarez A., Lopez P., Gomez J., Gutierrez C. Enrichment of CD4+ CD25high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids. Ann. Rheum. Dis. 2006, 65:1512-1517.
30. Tai P., Wang J., Jin H., Song X., Yan J., Kang Y., Zhao L., An X., Du X., Chen X., Wang S., Xia G., Wang B. Induction of regulatory T cells by physiological level estrogen. J. Cell Physiol. 2008, 214:456-464.
31. Verhasselt V., Vosters O., Beuneu C., Nicaise C., Stordeur P., Goldman M. Induction of FOXP3-expressing regulatory CD4pos T cells by human mature autologous dendritic cells. Eur. J. Immunol. 2004, 34:762-772.
32. Walker M.R., Carson B.D., Nepom G.T., Ziegler S.F., Buckner J.H. De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4+. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:4103-4108.
33. Walker M.R., Kasprowicz D.J., Gersuk V.H., Benard A., Van L.M., Buckner J.H., Ziegler S.F. Induction of FOXP3 and acquisition of T regulatory activity by stimulated human CD4+. J. Clin. Invest. 2003, 112:1437-1443.
34. Wang J., Ioan-Facsinay A., van d V., Huizinga T.W., Toes R.E. Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur. J. Immunol. 2007, 37:129-138.
35. Zhang B., Zhang X., Tang F., Zhu L., Liu Y. Reduction of forkhead box P3 levels in CD4+CD25high T cells in patients with new-onset systemic lupus erythematosus. Clin. Exp. Immunol. 2008, 153:182-187.
36. Ziegler S.F. FOXP3: of mice and men. Annu. Rev. Immunol. 2006, 24:209-226.